SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-09-053891
Filing Date
2009-03-13
Accepted
2009-03-13 16:28:55
Documents
9
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1162428
2 SECOND AMENDMENT TO LICENSE, DEVELOPMENT AND MARKETING AGREEMENT dex1062.htm EX-10.62 19003
3 AMENDED AND RESTATED DIRECTOR COMPENSATION POLICY dex1063.htm EX-10.63 19334
4 CONSENT OF PRICEWATERHOUSECOOPERS LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING. dex231.htm EX-23.1 1938
5 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 8529
6 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 8293
7 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 4162
8 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 4144
9 GRAPHIC g34820g47y05.jpg GRAPHIC 56890
  Complete submission text file 0001193125-09-053891.txt   1307779
Mailing Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466
Business Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466 9199419777
INSPIRE PHARMACEUTICALS INC (Filer) CIK: 0001040416 (see all company filings)

IRS No.: 043209022 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-31577 | Film No.: 09680458
SIC: 2834 Pharmaceutical Preparations